Fortitude Family Office, LLC Heron Therapeutics, Inc. Transaction History
Fortitude Family Office, LLC
- $430 Billion
- Q4 2025
A detailed history of Fortitude Family Office, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 79 shares of HRTX stock, worth $86. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79
Previous 89
11.24%
Holding current value
$86
Previous $112,000
8.04%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HRTX
# of Institutions
188Shares Held
151MCall Options Held
20.1KPut Options Held
2.12M-
Rubric Capital Management LP New York, NY29.1MShares$32 Million0.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.2MShares$11.3 Million0.02% of portfolio
-
Clearline Capital LP New York, NY9.71MShares$10.7 Million0.62% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA8.75MShares$9.63 Million21.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.46MShares$9.31 Million0.0% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $131M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...